Skip to content

Bellicum Pharmaceuticals, Inc.: filings

Every Bellicum Pharmaceuticals, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 35 filings, each linked to its SEC index.

Filing record ends 2023-11-14

The latest filing in this captured record is a 10-Q filed 2023-11-14. No later filing is in the SEC companyfacts record captured on 2026-09-22. Bellicum Pharmaceuticals, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-11-14fiscal Q3 2023321030001628280-23-038953
10-Q2023-08-10fiscal Q2 202332990001628280-23-028893
10-Q2023-05-11fiscal Q1 202332680001628280-23-017582
10-K2023-03-31fiscal FY 202241830001628280-23-010145
10-Q2022-11-10fiscal Q3 2022351090001628280-22-029487
10-Q2022-08-11fiscal Q2 2022341010001628280-22-022466
10-Q2022-05-12fiscal Q1 202233690001628280-22-014112
10-K2022-03-24fiscal FY 202142860001628280-22-007196
10-Q2021-11-04fiscal Q3 2021391170001628280-21-021750
10-Q2021-08-12fiscal Q2 2021381090001628280-21-016814
10-Q2021-05-14fiscal Q1 202138790001628280-21-010329
10-K2021-03-31fiscal FY 202041820001628280-21-006164
10-Q2020-11-05fiscal Q3 2020361030001358403-20-000027
10-Q2020-08-06fiscal Q2 202035950001358403-20-000021
10-Q2020-05-07fiscal Q1 202040830001358403-20-000016
10-K2020-03-12fiscal FY 2019411060001358403-20-000007
10-Q2019-11-06fiscal Q3 2019401090001358403-19-000123
10-Q2019-08-05fiscal Q2 2019401040001358403-19-000106
10-Q2019-05-07fiscal Q1 201939800001358403-19-000058
10-K2019-03-12fiscal FY 2018381020001358403-19-000038
10-Q2018-11-06fiscal Q3 201836920001358403-18-000099
10-Q2018-08-07fiscal Q2 201834880001358403-18-000086
10-Q2018-05-08fiscal Q1 201833680001358403-18-000047
10-K2018-03-13fiscal Q4 2017341050001358403-18-000037
10-Q2017-11-07fiscal Q3 201735880001358403-17-000164
10-Q2017-08-08fiscal Q2 201734840001358403-17-000150
10-Q2017-05-08fiscal Q1 201733660001358403-17-000073
10-K2017-03-13fiscal Q4 2016361090001358403-17-000050
10-Q2016-11-09fiscal Q3 201631820001358403-16-000292
10-Q2016-08-08fiscal Q2 201630770001358403-16-000248
10-Q2016-05-09fiscal Q1 201629610001358403-16-000181
10-K2016-03-14fiscal Q4 2015341080001358403-16-000158
10-Q2015-11-09fiscal Q3 201529760001358403-15-000093
10-Q2015-08-13fiscal Q2 201529760001358403-15-000066
10-Q2015-05-12fiscal Q1 201528580001358403-15-000014

Inspect the source

Entity
Bellicum Pharmaceuticals, Inc. / CIK 0001358403
Captured
SEC response SHA-256
f690be12c8bf2f33935869373fdcd3814c86e77c8faf335222b9df4fc3bb06d0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001358403.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))